Opinion EDITORIAL How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic Lauren M. Madigan, MD; Robert G. Micheletti, MD; Kanade Shinkai, MD, PhD In this issue of JAMA Dermatology, clinical cases and images may present at any stage of the infection. In cases we have seen of rashes in patients infected with severe acute respiratory as medical dermatologists, rashes may precede the onset of fe- 1,2 ver and other systemic features, and they may also occur late syndrome coronavirus 2 (SARS-CoV-2) are presented. Although these early observations are not comprehensive of during the infection, including after other typical viral fea- all skin manifestations seen, tures have subsided. our intention in publishing Key histopathologic features vary depending on the mor- Related articles pages 820 and them is to help dermatolo- phologic presentation. Collaborations between dermatolo- gists recognize emerging pat- gists and dermatopathologists will be essential to character- terns of rashes in patients with coronavirus disease 2019 ize these eruptions, both to identify histopathologic features (COVID-19). The reported prevalence of cutaneous signs in as- (if any) that are specific to COVID-19 and may guide the treat- sociation with this pandemic is conflicting; one study re-
JAMA Dermatology – American Medical Association
Published: Jul 30, 2020
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera